Prevalence of HIV and Treponema pallidum infections in pregnant women in Campinas and their association with socio-demographic factors
Keywords:
Human immunodeficiency virus, HIV, prevalence women, gestation, Umbilical cord bloodAbstract
The anonymous seroprevalence of HIV and syphilis was studied by collecting umbilical cord blood samples from 5,815 women who gave birth in Campinas' hospitals throughout a six-month period. ELISA and Western blot were used for HIV, and VDRL and TPHA for Treponema pallidum screening. While maintaining the anonymity of the women, information was recorded on the hospital of origin, divided into university (public) and private hospitals, as well as on the form of payment (social security, private insurance or direct payment), age, marital status, education, employment and place of residence. Seroprevalence was 0.42 percent for HIV and 1.16 percent for syphilis. There was a significant correlation between a positive reaction to the two infections (p=0.02). After univariate and logistic regression analysis, only university hospitals were shown to be associated with seropositivity for HIV, whereas the same variable and an older age were associated with syphilis. All positive reactions were found either in public hospitals or among social security patients treated at private institutions. The conclusion was that HIV infection is becoming almost as prevalent as syphilis among this population, and affects primarily the lower socio-economic strata. This suggests that routine, voluntary HIV serology should be considered and discussed with patients during prenatal or delivery care whenever a population shows a seroprevalence close to or greater than 1 percent.
Downloads
References
ACOG-Committee Opinion: Committee on Ethics. Human immunodeficiency virus infection: physicians' responsibilities. Int J Gynecol Obstet 1991;36:340-2.
Amaral E, Passini R Jr, Faúndes A, et al. Infecção pelo HIV em Obstetrícia: Revisão e reflexão sobre as várias faces de um problema. Femina 1991;19:104-14.
Avins AL, Lo B. To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiological research. Am J Publ Health 1989;79:1544-8.
Barbacci M, Repke J, Chaisson R. Routine prenatal screening for HIV infection. Lancet 1991;337:709-11.
Barton JJ, O'Connor TM, Cannon MJ, et al. Prevalence of human immunodeficiency virus in a general prenatal population. Am J Obstet Gynecol 1989;160:1316-24.
Bayer R , Lumey LH, Wan L. The American, British and Dutch responses to unlinked anonymous HIV seroprevalence studies: an international comparison. AIDS 1990;4:283-90.
Bayer R. The ethics of blind HIV surveillance testing. Am J of Public Health 1993;83:496-7.
BIOÉTICA. A ética da triagem sorológica não vinculada para o vírus da imunodeficiência humana (HIV). Bioética 1994;2(1):108.
Blanche S, Rouzioux C, Moscato MLG, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-8.
Ministério Da Saúde, Brasil. Pré-natal de baixo risco. Normas e Manuais Técnicos. Brasília 1986.
Ministério Da Saúde, Brasil. AIDS - Recomendações Técnicas e Aspectos Éticos. Brasília 1988.
Ministério Da Saúde, Brasil. In: Boletim Epidemiológico AIDS. Ano VI, Nº 4, Brasilia, Semana Epidemiológica. May 14-17, 1993.
Buchbinder S, Katz M, Hessol N, et aI. Health long-term positive: men infected with HIV for more than 10 years with CD4 counts > 500 cells. In: Final Program & Oral Abstracts of the VIII International Conference On Aids, Amsterdam, 1992:tU41(tuc O572).
Center For Disease Control. Public health service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. M M W R 1987;36:509-15.
Center For Disease Control. Recommendations for prevention of HIV transmission in health-care settings. M M W R 1987; 36(suppl:1S-18S).
Center For Disease Control. Update: universal precautions for prevention of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in health-care settings. M M W R 1988;37:377.
Center For Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus Type 1 infections. M M W R 1989;38(S-7):1.
Chateauvert M, Duffie A, Gilmore. N. Human immunodeficiency virus antibody testing: Counseling guidelines from the Canadian Medical Association: Ottawa:Can. Med. Assoc. 1990.
Diniz EM. Aspectos epidemiológicos e sorológicos da Síndrome de Imunodeficiência Adquirida em população de alto risco para doenças sexualmente transmissíveis. São Paulo 1990. (Thesis - School of Medicine, Universidade de São Paulo)
Dondero TJ, Curran JW. Serosurveillance of Human Immunodeficiency Virus infection. Am J Publ Health 1991;81:561-2.
Duarte G, Pinhata MM, Pasti MJ, et al. Problemas práticos na determinação da prevalência e assistência às parturientes com sorologia positiva para HIV. In: XV Congresso Brasileiro de Ginecologia e Obstetrícia, São Paulo, 1989.
Duarte G, Mussi-Pinhata MM, Del Lama J., et al. Valor de questionário específico na identificação de parturientes de risco para infecção pelo vírus da imunodeficiência humana (HIV). J Bras Ginecol 1991;101:169-74.
Duarte G, Quintana FM, Marana HRC, et al. Does the diagnosis of other STD identify parturients at risk for HIV infection? In: Final Program & Oral Abstract of the VIII International Conference On Aids, Amsterdam, 1992:B171(PoB3508)
European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet 1991;337:253-61.
European Collaborative Study. Risk factors for mother-tochild transmission of HIV-1. Lancet 1992;339:1007-1012.
Giraldes PR, Santos MC, Rivetti PS, et al. Pesquisa de anticorpos anti-HIV pelo teste ELISA na rotina pré-natal. Rev Bras Med 1989;46:106-8.
Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States: Surveillance using newborn blood samples. JAMA 1991;265:1704-8.
Hassig SE, Kinkela N, Nsa W, et al. Prevention of perinatal HIV transmission: are there alternatives to pre-pregnancy serological screening in Kinshasa, Zaire? AIDS 1990;4:913-16.
Henderson DK, Fahey BJ, Willy M, et al. Risk of occupacional transmission of immunodeficiency virus Type 1 (HIV-1) associated with clinical exposure: a prospective evaluation. Ann Intern Med 1990;113:740-6.
Hoff R, Berardi VP, Weiblen BJ, et al. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. N Engl J Med 1988; 318:525-30.
Hull HF, Bettinger CJ, Gallaher MM, et al. Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic. JAMA 1988;260:935-8.
Krueger LE, Wood RW, Diehr PH, et al. Poverty and HIV seropositivity: the poor are more likely to be infected. AIDS 1990;4:811-14.
Landesman S, Minkoff H, Holman S, et al. Serosurvey of human immunodeficiency virus infection in parturients. Implications for human immunodeficiency virus testing programs of pregnant women. JAMA 1987;258:2701-3.
Lindsay MK, Adefris W, Peterson HB, et al. Determinants of acceptance of routine voluntary Human Immunodeficiency Virus testing in an inner-city prenatal population. Obstet Gynecol 1991;78:678-80.
Lindsay MK, Peterson HB, Willis S, et al. Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990. Am J Obstet Gynecol 1991;165:961-4.
Mann JM. Global AIDS in the 1990's. J Acq Immun Def Synd 1990;3:348.
Miller JL, Meyer PG, Parrott NA, et al. A study of the biologic falsely positive reactions for syphilis in children. J Pediatr 1960;57:548-52.
Organisación Panamericana De La Salud. Relatório da I Reunião Latinoamericana sobre SIDA/AIDS Materno-Infantil na Região das Américas. São Paulo, 1990.
Organisation Mondiale De La Santé. Pandemie d' infection a VIHSIDA: situation actuelle et tendances futures. Recapitulation. Geneva. January 1992.
Piot P, Plummer FA, Mhalu FS, et al. AIDS: An International Perspective. Science 1988;239:573-9.
Piot P, Laga M, Ryder R, et al. The global epidemiology of HIV infection: continuity, heterogeneity and change. J Acq Immun Def Synd 1990;3:403-12.
Piot P. Epidemiology of STDs: State-of-the-Art. In: Final Program & Oral Abstracts of the VIII International Conference On Aids, Amsterdam, 1992.
Porto AGM. Prevalence of acquired immunodeficiency syndrome detected during prenatal care of a population of low socio-economic status. Am J Obstet Gynecol 1991;164:705-6.
Rawstron SA, Bromberg K. Comparison of maternal and newborn serologic tests for syphilis. A J D C 1991;145:1383-8.
Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus Type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-42.
Schechter M. AIDS III - Mal ataca 8 em cada mil gestantes. Súmula Radis. Fiocruz. Ano VIII, junho, 1991.
Slutkin G, Chin J, Tarantola D, et al. Sentinel surveillance for HIV infection: a method to monitor HIV infection trends in population groups. Global Programme on AIDS, W.H.O. In: IV International Conference On Aids, Geneva, June 1988.
Slutkin G, Chin J, Tarantola D, et al. Use of HIV surveillance data in National AIDS Control Programmes. A review of current data use with recommendations for strengthening future use. Global Programme on AIDS. World Health Organization, Geneva, 1990.
Tovo PA, Martino M. Epidemiology, clinical features and prognostic factors of pediatric HIV infection. Italian multicentre study. Lancet 1988;5:1043-5.
Wenstrom KD, Zuidema LJ. Determination of seroprevalence of human immunodeficiency virus infection in pregnant womean by non-anonimous versus anonimous testing. Obstet Ginecol 1989;74:558-61.
World Health Organization. Current and future dimensions of the HIV/AIDS pandemic: A capsule summary. Geneva, April 1991.
World Health Organization-Surveillance, Forecasting And Impact Assessment Unit (SFI). Update: AIDS cases reported to Global Programme on AIDS. Geneva, July 1991.
